TrademarkOpen
Search / US trademark / 98918795
US trademark

APSILON

Allowed — statement of use stage
First Extension - Granted

Status timeline

  1. 23 Dec 2024
    Application filed
    New Application Entered
  2. 5 Mar 2025
    Assigned to an examining attorney
    Assigned To Examiner
  3. 28 May 2025
    Response to office action filed
    Teas Response To Office Action Received
  4. 20 Jun 2025
    Approved for publication
    Approved For Pub - Principal Register
  5. 29 Jul 2025
    Published for opposition
    Published For Opposition
  6. 23 Sep 2025
    Notice of allowance issued — statement of use required
    Noa E-Mailed - Sou Required From Applicant
  7. 9 Mar 2026
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
All 21 USPTO events
2026-03-10Notice Of Approval Of Extension Request E-Mailed
2026-03-09Sou Teas Extension Received
2026-03-09Sou Extension 1 Filed
2026-03-09Sou Extension 1 Granted
2025-11-05Teas Change Of Owner Address Received
2025-11-05Applicant/Correspondence Changes (Non-Responsive) Entered
2025-11-05Teas Change Of Correspondence Received
2025-09-23Noa E-Mailed - Sou Required From Applicant
2025-07-29Published For Opposition
2025-07-29Official Gazette Publication Confirmation E-Mailed
2025-07-23Notification Of Notice Of Publication E-Mailed
2025-06-20Approved For Pub - Principal Register
2025-05-28Teas Response To Office Action Received
2025-05-28Correspondence Received In Law Office
2025-05-28Teas/Email Correspondence Entered
2025-03-12Priority Action Written
2025-03-12Priority Action E-Mailed
2025-03-12Notification Of Priority Action E-Mailed
2025-03-05Assigned To Examiner
2024-12-23New Application Entered
2024-12-23New Application Office Supplied Data Entered

Goods & services

Class 5 Pharmaceuticals & supplements

diagnostic preparations for medical purposes; biological preparations, namely, reagents for veterinary purposes; chemical preparations for medical purposes, namely for detection of infectious diseases, cancer markers, genetic diseases and metabolic diseases; chemical preparations for veterinary purposes, namely for extraction of nucleic acid; chemical reagents for medical or veterinary purposes; enzymes for medical purposes; enzymes for veterinary purposes; enzyme preparations for medical purposes; enzyme preparations for veterinary purposes; diagnostic preparations for medical purposes used by medical laboratories

Source & freshness

Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 11 Mar 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.